⌘K
t
BSF Enterprise PLC announced on 15 December 2025 an update to the timetable for its proposed Equity Fundraise and Capital Reorganisation. The company now seeks FCA approval for its Prospectus before 28 February 2026, prior to the previously announced 26 May 2026 deadline. The record date for the Capital Reorganisation is expected to be 26 February 2026, with New Ordinary Shares credited to CREST accounts on 27 February 2026.
| Date | 15 Dec 2025 |
| Time | 07:00:09 |
| Category | Miscellaneous |
| ID | 4755L |
15 December 2025
BSF Enterprise PLC
("BSF" or the "Company")
Changes to timetable for proposed Equity Fundraise and Capital Reorganisation
Further to the Company's announcements and despatch of the Notice of General Meeting on 28 November 2025, the Company provides an update on the proposed Equity Fundraise and Capital Reorganisation. Capitalised terms in this announcement have the same meaning as in the Notice of General Meeting, unless the context indicates otherwise.
Equity Fundraise
As previously announced, the Equity Fundraise is conditional on, inter alia, the FCA's approval of the Prospectus to be issued by the Company within 180 days from the date of CLN, expiring on 26 May 2026. The Company is seeking to obtain the approval of the Prospectus before 28 February 2026.
Update on Capital Reorganisation
It is now expected that the record date for the Capital Reorganisation will take place on or around 26 February 2026, and the expected date for CREST to be credited with New Ordinary Shares held in uncertificated form (where applicable) is on or around 27 February 2026.
Full details of the proposed Capital Reorganisation are set out in the Notice of General Meeting sent to the Shareholders on 28 November 2025. The Directors' unanimous recommendation for the Shareholders to vote in favour of the Resolutions is unchanged from that included in the Notice of General Meeting.
An announcement will be made following the General Meeting to confirm the status of the Resolutions.
The Company anticipates that the timetable for the proposed Equity Fundraise and Capital Reorganisation will be as follows:
Expected Timetable of Principal Events
|
Publication of Notice of General Meeting and Forms of Proxy |
28 November 2025 |
|
Latest time and date for receipt of Forms of Proxy and CREST Proxy Instructions for the General Meeting |
10.00 a.m. on 15 December 2025 |
|
Time and date of the General Meeting |
10.00 a.m. on 17 December 2025 |
|
Announcement of results of the General Meeting |
17 December 2025 |
|
Record time and date for Capital Reorganisation |
6.00 p.m. on 26 February 2026 |
|
Latest time and date for dealing in Existing Ordinary Shares |
6.00 p.m. on 26 February 2026 |
|
Expected date of Admission and first day of dealings in New Ordinary Shares on the Main Market |
27 February 2026 |
|
Expected date CREST accounts are to be credited with New Ordinary Shares in uncertificated form |
27 February 2026 |
|
Despatch of definitive certificate for New Ordinary Shares (in certificated form) |
By 20 March 2026 |
END
For more information and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: https://bsfenterprise.com/link/PREaXr.
For further enquiries, please visit www.bsfenterprise.com or contact:
|
BSF Enterprise PLC Geoff Baker - Executive Director Che Connon - CEO & Director
|
https://bsfenterprise.com/s/a1f22b
|
|
Shard Capital (Broker) Damon Heath Isabella Pierre |
0207 186 9000 0207 186 9927 |
|
ISIN of the Ordinary Shares is GB00BHNBDQ51. SEDOL Code is BHNBDQ5.
|
|
Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43
About BSF Enterprise PLC
BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations.